https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-472014-07-17 00:00:002019-02-15 08:49:40Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-05 / Virology 2014 Aug;462-463:283-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-05 / Virology 2014 Aug;462-463:283-942014-07-05 00:00:002019-02-15 09:21:23ISG12a mediates cell response to Newcastle disease viral infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-672014-07-03 00:00:002019-02-15 09:22:39Going viral with cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-01 / Immunology 2014 Jul;142(3):396-405
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-01 / Immunology 2014 Jul;142(3):396-4052014-07-01 00:00:002019-02-15 08:49:49Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-01 / Yonsei Med. J. 2014 Jul;55(4):1014-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-01 / Yonsei Med. J. 2014 Jul;55(4):1014-272014-07-01 00:00:002019-02-15 08:52:43Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-01 / Cancer 2014 Nov;120(21):3418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-01 / Cancer 2014 Nov;120(21):3418-252014-07-01 00:00:002014-07-01 00:00:00Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-30 / Cell. Mol. Immunol. 2015 Jan;12(1):87-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-30 / Cell. Mol. Immunol. 2015 Jan;12(1):87-952014-06-30 00:00:002019-02-15 08:52:07Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-18 / J. Immunol. 2014 Jul;193(2):735-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-18 / J. Immunol. 2014 Jul;193(2):735-452014-06-18 00:00:002019-02-15 09:21:24Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-11 / Front Oncol 2014;4:145
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-11 / Front Oncol 2014;4:1452014-06-11 00:00:002019-02-15 09:22:41Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-402014-06-09 00:00:002019-02-15 08:52:08Ovarian cancer biology and immunotherapy
